HomePROGEN • STO
add
Prostatype Genomics AB
Previous close
kr 1.15
Day range
kr 1.01 - kr 1.15
Year range
kr 0.28 - kr 5.66
Market cap
65.70M SEK
Avg Volume
747.13K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 174.00K | -25.96% |
Operating expense | -578.50K | -111.14% |
Net income | -10.29M | 3.75% |
Net profit margin | -5.91K | -29.99% |
Earnings per share | — | — |
EBITDA | -8.89M | 13.00% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 9.07M | -3.74% |
Total assets | 50.86M | 21.19% |
Total liabilities | 24.33M | 186.24% |
Total equity | 26.53M | — |
Shares outstanding | 59.19M | — |
Price to book | 2.56 | — |
Return on assets | -46.38% | — |
Return on capital | -88.93% | — |
Cash Flow
Net change in cash
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -10.29M | 3.75% |
Cash from operations | -3.36M | 68.73% |
Cash from investing | -6.02M | -560.26% |
Cash from financing | 7.45M | -51.82% |
Net change in cash | -1.93M | -150.61% |
Free cash flow | -11.79M | -65.40% |
About
Founded
2007
Website
Employees
6
